Meeting
2017 ASCO Annual Meeting
Effect of Ga-68 PSMA-11 PET on management in patients with recurrent prostate cancer.
Authors
Tom Hope
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Tom Hope , Rahul Raj Aggarwal , Kirsten L Greene , Bryant Chee , Dora Tao , Felix Yi-Chung Feng , Albert Chang , Matthew R. Cooperberg , Charles J. Ryan , Eric Jay Small , Peter Carroll
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT02611882
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5057)
DOI
10.1200/JCO.2017.35.15_suppl.5057
Abstract #
5057
Poster Bd #
131
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.
First Author: Richard Bennett IV
Poster
2021 ASCO Annual Meeting
Diagnostic performance of Gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging in early-relapsed prostate cancer: Phase 3, prospective, multicenter study (IAEA-PSMA study).
First Author: Juliano J Cerci
Poster
2019 Genitourinary Cancers Symposium
Identification of bone involvement in patients with prostate cancer recurrence using 18F-fluciclovine PET/CT and impact on subsequent management.
First Author: Michael S Kipper
Poster
2024 ASCO Genitourinary Cancers Symposium
Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States.
First Author: Michael Leapman